Literature DB >> 6699695

Ultrastructural study of the formation of psammoma bodies in fibroblastic meningioma.

T Kubota, K Sato, S Yamamoto, A Hirano.   

Abstract

The fine structure of psammoma bodies was examined in four cases of fibroblastic meningioma. In general, large numbers of various-sized calcified bodies (psammoma bodies) were scattered among the interstitial fibers. In these bodies, the smallest calcific site was found in the extracellular membrane-bound matrix vesicles, which measured approximately 0.1 to 0.2 mu in diameter. In addition, extracellular "matrix giant bodies," with or without hydroxyapatite aggregates and measuring up to 3 mu in diameter, were frequently encountered. These bodies were apparently invested with single, double, or multiple concentric walls averaging nearly 0.1 mu thick. The presumably originated from the neoplastic cells as a consequence of cytoplasmic residuals associated with cellular degeneration or necrotic cell processes. Hydroxyapatite crystals precipitated repeatedly within the bodies. The precipitate may gradually aggregate within the bodies, and gather in clusters, resulting in a large psammoma body. Finally, collagen fibers around the calcified giant bodies accrued deposits of apatite crystals to make a huge psammoma body. These findings suggest that both matrix giant bodies and matrix vesicles may serve as initial nidus of calcification of psammoma bodies in fibroblastic meningioma. Consequently, this mineralization process may represent a certain dystrophic calcification of meningocytic cells.

Entities:  

Mesh:

Year:  1984        PMID: 6699695     DOI: 10.3171/jns.1984.60.3.0512

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  10 in total

1.  Formation of psammoma bodies in meningocytic whorls. Ultrastructural study and analysis of calcified material.

Authors:  T Kubota; T Yamashima; M Hasegawa; S Kida; M Hayashi; S Yamamoto
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

2.  The origin of psammoma bodies in the human arachnoid villi.

Authors:  T Yamashima; S Kida; T Kubota; S Yamamoto
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

3.  Fine structure of psammoma bodies at the outer aspect of blood vessels in meningioma.

Authors:  T Kubota; A Hirano; K Sato; S Yamamoto
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

4.  Spinal meningioma containing bone: a case report and review of literature.

Authors:  Mohammad Tahir; Nida Usmani; Faiz U Ahmad; Sueba Salmani; Manish S Sharma
Journal:  BMJ Case Rep       Date:  2009-04-14

5.  Totally ossified metaplastic spinal meningioma.

Authors:  Chang Il Ju; Kazutoshi Hida; Tomohiro Yamauchi; Kiyohiro Houkin
Journal:  J Korean Neurosurg Soc       Date:  2013-09-30

6.  Ossified Spinal Meningioma: A Case Report and a Review of the Literature.

Authors:  Mahmoud M Taha; Ahmed Alawamry; Hesham R Abdel-Aziz
Journal:  Surg J (N Y)       Date:  2019-10-01

Review 7.  Thoracic psammomatous meningioma with osseous metaplasia: a controversial diagnosis of a case report and literature review.

Authors:  Chao Wang; Yunqing Chen; Lu Zhang; Xuexiao Ma; Bohua Chen; Shuzhong Li
Journal:  World J Surg Oncol       Date:  2019-08-24       Impact factor: 2.754

8.  Multiple ossified spinal meningiomas in the thoracic spine: A case report and literature review.

Authors:  Chunke Dong; Yi Liu; Yuting Zhu; Hongyu Wei; Yuzhuo Ma
Journal:  Front Surg       Date:  2022-10-04

Review 9.  Functional State of Cells During their Life and on their Journey Toward Inactivity and Death: Search for Morphological Evidence in Thyroid Fine Needle Aspiration Smears.

Authors:  Dilip K Das
Journal:  J Cytol       Date:  2018 Jul-Sep       Impact factor: 1.000

10.  CT Hounsfield Unit Is a Good Predictor of Growth in Meningiomas.

Authors:  Satoshi Nakasu; Takeshi Onishi; Sawako Kitahara; Hisayuki Oowaki; Ken-Ichi Matsumura
Journal:  Neurol Med Chir (Tokyo)       Date:  2019-01-26       Impact factor: 1.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.